272 related articles for article (PubMed ID: 2554691)
1. Role of bone and kidney in parathyroid hormone-related peptide-induced hypercalcemia in rats.
Rizzoli R; Caverzasio J; Chapuy MC; Martin TJ; Bonjour JP
J Bone Miner Res; 1989 Oct; 4(5):759-65. PubMed ID: 2554691
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of parathyroid hormone secretion and parathyroid hormone-independent diminution of tubular calcium reabsorption by WR-2721, a unique hypocalcemic agent.
Hirschel-Scholz S; Caverzasio J; Bonjour JP
J Clin Invest; 1985 Nov; 76(5):1851-6. PubMed ID: 2997292
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone-like changes in renal calcium and phosphate reabsorption induced by Leydig cell tumor in thyroparathyroidectomized rats.
Rizzoli R; Caverzasio J; Fleisch H; Bonjour JP
Endocrinology; 1986 Sep; 119(3):1004-9. PubMed ID: 3755393
[TBL] [Abstract][Full Text] [Related]
4. Action of tumoral PTH-related peptide on phosphate and calcium transport.
Bonjour JP; Rizzoli R; Pizurki L; Caverzasio J
Prog Clin Biol Res; 1990; 332():39-49. PubMed ID: 2158662
[TBL] [Abstract][Full Text] [Related]
5. Normalization of hypercalcemia associated with a decrease in renal calcium reabsorption in Leydig cell tumor-bearing rats treated with WR-2721.
Hirschel-Scholz S; Caverzasio J; Rizzoli R; Bonjour JP
J Clin Invest; 1986 Jul; 78(1):319-22. PubMed ID: 3013941
[TBL] [Abstract][Full Text] [Related]
6. Interference of WR-2721 with magnesium metabolism: mechanism of action.
Hirschel-Scholz S; Paunier L; Bonjour JP
Miner Electrolyte Metab; 1988; 14(2-3):114-20. PubMed ID: 2837628
[TBL] [Abstract][Full Text] [Related]
7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
8. Actions of parathyroid hormone and parathyroid hormone-related protein.
Rizzoli R; Ferrari SL; Pizurki L; Caverzasio J; Bonjour JP
J Endocrinol Invest; 1992; 15(9 Suppl 6):51-6. PubMed ID: 1338636
[TBL] [Abstract][Full Text] [Related]
9. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
[TBL] [Abstract][Full Text] [Related]
10. Factor derived from human lung carcinoma associated with hypercalcemia mimics the effects of parathyroid hormone on phosphate transport in cultured renal epithelia.
Pizurki L; Rizzoli R; Caverzasio J; Mundy G; Bonjour JP
J Bone Miner Res; 1988 Apr; 3(2):233-9. PubMed ID: 3213617
[TBL] [Abstract][Full Text] [Related]
11. Interaction of calcitonin with vitamin D and prostaglandin E2 on renal tubular reabsorption of calcium in thyroparathyroidectomized rats.
Su KW; Matsumoto T; Takahashi H; Yamamoto M; Ogata E
Miner Electrolyte Metab; 1988; 14(4):229-34. PubMed ID: 2850461
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA
Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449
[TBL] [Abstract][Full Text] [Related]
13. Resistance to the phosphaturic and calcemic actions of parathyroid hormone during phosphate depletion. Prevention by 1,25-dihydroxyvitamin D3.
Gloor HJ; Bonjour JP; Caverzasio J; Fleisch H
J Clin Invest; 1979 Mar; 63(3):371-7. PubMed ID: 34630
[TBL] [Abstract][Full Text] [Related]
14. Stimulation by interleukin-1 of renal calcium reabsorption in thyroparathyroidectomized rats.
Caverzasio J; Rizzoli R; Vallotton MB; Dayer JM; Bonjour JP
J Bone Miner Res; 1993 Oct; 8(10):1219-25. PubMed ID: 8256659
[TBL] [Abstract][Full Text] [Related]
15. Difference between 1-84 parathyroid hormone and the 1-34 fragment on renal tubular calcium transport in the dog.
Puschett JB; McGowan J; Fragola J; Chen TC; Keutmann H; Rosenblatt M
Miner Electrolyte Metab; 1984; 10(4):271-4. PubMed ID: 6749074
[TBL] [Abstract][Full Text] [Related]
16. Quantitative evaluation of anticalciuretic effects of synthetic parathyroid hormonelike peptides.
Scheinman SJ; Mitnick ME; Stewart AF
J Bone Miner Res; 1990 Jun; 5(6):653-8. PubMed ID: 2166424
[TBL] [Abstract][Full Text] [Related]
17. Potentiation by calcium of the proximal tubular transport effects of parathyroid hormone.
Winaver J; Fragola J; Chen TC; Sylk DB; Robertson JS; Puschett JB
Miner Electrolyte Metab; 1982 Nov; 8(5):275-88. PubMed ID: 6300634
[TBL] [Abstract][Full Text] [Related]
18. Synthetic human parathyroid hormone-related protein and rat renal electrolyte transport.
Carney SL; Ray C; Ebeling PR; Martin TJ; Gillies AH
Miner Electrolyte Metab; 1991; 17(1):41-5. PubMed ID: 1663207
[TBL] [Abstract][Full Text] [Related]
19. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone.
Hock JM; Gera I
J Bone Miner Res; 1992 Jan; 7(1):65-72. PubMed ID: 1532281
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 beta stimulates bone resorption and inhibits bone formation in vivo.
Nguyen L; Dewhirst FE; Hauschka PV; Stashenko P
Lymphokine Cytokine Res; 1991 Apr; 10(1-2):15-21. PubMed ID: 1873357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
